NYSE - Nasdaq Real Time Price USD

Innovid Corp. (CTV)

2.2600 0.0000 (0.00%)
As of 2:56 PM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 2222
Avg. Estimate -0.0100.010.05
Low Estimate -0.02000.05
High Estimate -0.0100.020.05
Year Ago EPS -0.05-0.13-0.210.01

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 2233
Avg. Estimate 35M38.3M158.29M179.61M
Low Estimate 34.9M38M155M179M
High Estimate 35.1M38.6M161.88M180.54M
Year Ago Sales 30.48M32M139.88M158.29M
Sales Growth (year/est) 14.80%19.70%13.20%13.50%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. -0.05-0.03-0.01-0.01
EPS Actual -0.05-0.13-0.010
Difference 0-0.100.01
Surprise % 0.00%-333.30%0.00%100.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.0100.010.05
7 Days Ago -0.0100.010.05
30 Days Ago -0.0100.010.05
60 Days Ago -0.020-0.010.03
90 Days Ago -0.020-0.010.03

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD CTVIndustrySectorS&P 500
Current Qtr. 80.00%----1.50%
Next Qtr. 100.00%----11.40%
Current Year 104.80%----5.20%
Next Year 400.00%----13.40%
Next 5 Years (per annum) ------11.09%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

2.10 Low
2.45 Average
2.2600 Current
3.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Morgan Stanley: Equal-Weight to Equal-Weight 4/16/2024
Reiterates JMP Securities: Market Outperform to Market Outperform 4/10/2024
Maintains Morgan Stanley: Equal-Weight to Equal-Weight 2/28/2024
Reiterates Needham: Buy to Buy 2/27/2024
Maintains Needham: Buy to Buy 12/1/2023
Maintains Morgan Stanley: Equal-Weight to Equal-Weight 11/9/2023

Related Tickers